Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
05/05/2026 15:02
May 5 (Reuters) - Molecure SA MOCP.WA: ITS IN-CONSORTIUM PROJECT SELECTED FOR FUNDING BY MEDICAL RESEARCH AGENCY TOTAL GRANT RECOMMENDED FOR PROJECT IS ABOUT 12 MILLION ZLOTYS, WITH 6.9 MILLION ZLOTYS ALLOCATED TO THE COMPANY PROJECT BUDGET TOTALS ABOUT 14 MILLION ZLOTYS WITH IMPLEMENTATION SCHEDULED FOR 2026-2028 PROJECT AIMED AT DEVELOPING THERAPIES FOR AGGRESSIVE BLOOD CANCERS Source text: ID:nEM1NqpYa Further company coverage: MOCP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Molecure SA
See all newsBrief: Molecure H1 Net Loss At 6.3 Million Zlotys
Brief: Molecure Receives Positive IDMC Recommendation for KITE Trial
Brief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr